- Home
- NVAX vs SONO Comparison
NVAX vs SONO Comparison
Compare NVAX & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SONO
- Stock Information
- Founded
- NVAX 1987
- SONO 2002
- Country
- NVAX United States
- SONO United States
- Employees
- NVAX N/A
- SONO N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SONO Consumer Electronics/Video Chains
- Sector
- NVAX Health Care
- SONO Consumer Discretionary
- Exchange
- NVAX Nasdaq
- SONO Nasdaq
- Market Cap
- NVAX 2.0B
- SONO 1.4B
- IPO Year
- NVAX 1995
- SONO 2018
- Fundamental
- Price
- NVAX $9.76
- SONO $12.96
- Analyst Decision
- NVAX Buy
- SONO Hold
- Analyst Count
- NVAX 6
- SONO 3
- Target Price
- NVAX $17.83
- SONO $15.67
- AVG Volume (30 Days)
- NVAX 7.2M
- SONO 1.3M
- Earning Date
- NVAX 11-07-2024
- SONO 11-13-2024
- Dividend Yield
- NVAX N/A
- SONO N/A
- EPS Growth
- NVAX N/A
- SONO N/A
- EPS
- NVAX N/A
- SONO N/A
- Revenue
- NVAX $987,667,000.00
- SONO $1,567,823,000.00
- Revenue This Year
- NVAX N/A
- SONO N/A
- Revenue Next Year
- NVAX N/A
- SONO N/A
- P/E Ratio
- NVAX N/A
- SONO N/A
- Revenue Growth
- NVAX N/A
- SONO N/A
- 52 Week Low
- NVAX $3.53
- SONO $10.10
- 52 Week High
- NVAX $23.86
- SONO $19.76
- Technical
- Relative Strength Index (RSI)
- NVAX 36.20
- SONO 60.67
- Support Level
- NVAX $9.52
- SONO $12.76
- Resistance Level
- NVAX $10.63
- SONO $13.19
- Average True Range (ATR)
- NVAX 0.57
- SONO 0.36
- MACD
- NVAX -0.12
- SONO 0.06
- Stochastic Oscillator
- NVAX 9.97
- SONO 93.84
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About SONO Sonos Inc.
Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa, and the Asia Pacific. Generating a majority of its revenue from the Americas.